Press Releases :: Aethlon Medical, Inc. (AEMD)

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

Year

Category

Nov 14, 2023

Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

Nov 13, 2023

Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer

Nov 6, 2023

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

Oct 10, 2023

Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology

Oct 4, 2023

Aethlon Announces Reverse Stock Split

Aug 30, 2023

Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 10, 2023

Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update

Aug 3, 2023

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023

Jul 24, 2023

Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant

Jul 6, 2023

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors

rss_feed News RSS